Antiplatelet effects of caffeic acid due to Ca2+ mobilization- inhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 1, 2014, Pages 23-37

  Lee, Dong Ha ^a   Kim, Hyun Hong ^a   Cho, Hyun Jeong ^b   Bae, Jeong Soo ^a   Yu, Young Bin ^b   Park, Hwa Jin ^a  

^a Inje University   (South Korea)

^b Konyang University   (South Korea)

Author keywords

Caffeic acid; cAMP; Cyclooxygenase 1; Inositol 1, 4, 5 trisphosphate receptor phosphorylation

Indexed keywords

CAFFEIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYTOCHROME C; INOSITOL 1, 4, 5 TRISPHOSPHATE RECEPTOR; THROMBOXANE A2; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

ANIMALS; BLOOD PLATELETS; BLOTTING, WESTERN; CAFFEIC ACIDS; CALCIUM; CELL ADHESION MOLECULES; CYCLIC AMP; CYCLOOXYGENASE 1; ELECTROPHYSIOLOGY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MICROSOMES; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE A2;

EID: 84893011172     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.18994     Document Type: Article

References (48)

1. Schwartz SM, Heinmark RL, Majesky MW: Developmental mechanisms underlying pathology of arteries. Physiol Rev, 1990; 70: 1177-1209
2. Cattaneo M, Tenconi PM, Lecchi A, Mannucci PM: In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res, 1991; 62: 717-724
3. Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horrejsi V, Shattile SJ, Watson SP: Differential role of glycolipid-enriched membrane domane in glycoprotein VI-and integrin-mediated phospholipase C gamma2 regulation in platelets. Biochem J, 2002; 364: 755-765
4. Nishikawa M, Tanaka T, Hidaka H: Ca2+-calmodulindependent phosphorylation and platelet secretion. Nature, 1980; 287: 863-865
5. Kaibuchi K, Sano K, Hoshijima M, Takai Y, Nishizuka Y: Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium, 1982; 3: 323-335
6. Cipollone F, Patrignani P, Greco A, Panara MR, Padovano R, Cuccurullo F, Patrono C, Rebuzzi AG, Liuzzo G, Quaranta G, Maseri A: Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation, 1997; 96: 1109-1116
7. Jennings LK: Role of platelets in atherothrombosis. Am J Cardiol, 2009; 103: 4A-10A
8. Moriyama T, Takamura H, Narita H, Tanaka K, Matsuura T, Kito M: Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. J Biochem, 1988; 103: 901-902
9. Patrono C: Aspirin: new cardiovascular uses for an old drug. Am J Med, 2001; 110: 62-65
10. Ichikawa K, Tazawa S, Hamano S, Kojima M, Hiraku S: Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models. Pharmacology, 1999; 59: 257-265
11. Ok WJ, Cho HJ, Kim HH, Lee DH, Kang HY, Kwon HW, Rhee MH, Kim M, Park HJ: Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner. J Atheroscler Thromb, 2012; 19: 337-348
12. Lee DH, Kim YJ, Kim HH, Cho HJ, Ryu JH, Rhee MH, Park HJ: Inhibitory Effects of Epigallocatechin-3-Gallate on Microsomal Cyclooxygenase-1 Activity in Platelets. Biomol Ther, 2013; 21: 54-59
13. Chang WC, Hsu FL: Inhibition of platelet activation and endothelial cell injury by polyphenolic compounds iso lated from Lonicera japonica Thunb. Prostaglandins Leukot Essent Fatty Acids, 1992; 45: 307-312
14. Park JB: 5-Caffeoylquinic acid and caffeic acid orally administered suppress P-selectin expression on mouse platelets. J Nutr Biochem, 2009; 20: 800-805
15. Halbrügge M, Walter U: Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem, 1989; 185: 41-50
16. Halbrügge M, Friedrich C, Eigenthaler M, Schanzenbächer P, Walter U: Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP-and cAMP-elevating vasodilators. J Biol Chem, 1990; 265: 3088-3093
17. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U: cAMP-and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilatorstimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem, 1994; 269: 14509-14517
18. Schwarz UR, Walter U, Eigenthaler M: Taming platelets with cyclic nucleotides. Biochem Pharmac, 2001; 62: 1153-1161
19. Quinton TM, Dean WL: Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes. Biochem Biophys Res Commun, 1992; 184: 893-899
20. Cavallini L, Coassin M, Borean A, Alexandre A: Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem, 1996; 271: 5545-5551
21. Laurent V, Loisel TP, Harbeck B, Wehman A, Gröbe L, Jockusch BM, Wehland J, Gertler FB, Carlier MF: Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes. J Cell Biol, 1999; 144: 1245-1258
22. Sudo T, Ito H, Kimura Y: Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the antiplatelet drug, cilostazol, in platelets. Platelets, 2003; 14: 381-390
23. Menshikov MYu, Ivanova K, Schaefer M, Drummer C, Gerzer R: Influence of the cGMP analog 8-pCPT-cGMP on agonist-induced increases in cytosolic ionized Ca2+ and on aggregation of human platelets. Eur J Pharmacol, 1993; 245: 281-284
24. Chen TG, Lee JJ, Lin KH, Shen CH, Chou DS, Sheu JR: Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets. Chin J Physiol, 2007; 50: 121-126
25. Carey F, Menashi S, Crawford N: Localization of cyclooxygenase and thromboxane synthase in human platelet intracellular membranes. Biochem J, 1982; 204: 847-851
26. Lagarde M, Menashi S, Crawford N: Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett, 1981; 124: 23-26
27. Samuelsson B: Biosynthesis and metabolism of prostaglandins. Progression Biochemical Pharmacology, 1967; 3: 59-70
28. Sun FF, Chapman JP, McGuire JC: Metabolism of prostaglandin endoperoxide in animal tissues. Prostaglandins, 1977; 14: 1055-1074
29. Schaeffer J, Blaustein MP: Platelet free calcium concentrations measured with fura-2 are influenced by the transmembrane sodium gradient. Cell Calcium, 1989; 10: 101-113
30. Cho HJ, Ham HS, Lee TK, Jung YJ, Choi SA, Kang HC, Park HJ: Inhibitory effect of cordycepin on human platelet aggregation. J Biomed Lab Sci, 2004; 10: 1-8
31. Lewis GP, Watt IS: Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collageninduced aggregation of rabbit platelets. Br J Pharmac, 1982; 75: 623-631
32. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U: Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem, 2010; 285: 18352-18363
33. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM: The role of polyphenolic compounds in the diet as inhibitors of platelet function. Proc Nutr Soc, 2003; 62: 469-478
34. Kinlough-Rathbone RL, Packham MA, Reimers HJ, Cazenave JP, Mustard JF: Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. J Lab Clin Med, 1977; 90: 707-719
35. Charo IF, Feinman RD, Detwiler TC: Interrelations of platelet aggregation and secretion. J Clin Invest, 1977; 60: 866-873
36. Cho HJ, Kang HJ, Kim YJ, Lee DH, Kwon HW, Kim YY, Park HJ: Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner. Blood Coagul Fibrinolysis, 2012; 23: 629-635
37. Hamberg M, Svensson J, Samuelsson B: Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci (USA), 1975; 72: 2994-2998
38. Moncada S, Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev, 1978; 30: 293-331
39. Wang RG, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME: Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci (USA), 1998; 95: 4888-4893
40. Jang EK, Azzam JE, Cickinson NT, Davidson MM, Haslam RJ: Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br J Haematol, 2002; 117: 664-675
41. Hsiao G, Lee JJ, Lin KH, Shen CH, Fong TH, Chou DS, Sheu JR: Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies. Cardiovasc Res, 2007; 75: 782-792
42. Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H, Walter U: Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem, 1998; 273: 20029-20035
43. Horstrup K, Jablonka B, Hönig-Liedl P, Just M, Kochsiek K, Walter U: Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem, 1994; 225: 21-27
44. Eigenthaler M, Nolte C, Halbrügge M, Walter U: Concentration and regulation of cyclic nucleotides, cyclicnucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem, 1992; 205: 471-481
45. Olthof MR, Hollman PC, Katan MB: Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr, 2001; 131: 66-71
46. Clifford MN: Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric, 1999; 79: 362-372
47. Higdon JV, Frei B: Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr, 2006; 46: 101-123
48. Nardini M, Cirillo E, Natella F, Scaccini C: Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem, 2002; 50: 5735-5741